This Oracle Life Sciences Healthcare Research Privacy Policy (also referred to as the “Privacy Policy”) provides information on the collection, use, and sharing (collectively referred to “processing” or “process”) of personal information by Oracle Life Sciences, previously Cerner Enviza and its affiliates (“Oracle”, “we” or “us”) in connection with the personal information you provide to Oracle, either in electronic or paper format to facilitate Oracle research activities. This Privacy Policy also explains the privacy rights you have in relation to these processing activities.
This Privacy Policy was last updated on January 29, 2025. However, the Privacy Policy can change over time, for example, to comply with legal requirements or to meet changing business needs. The most up-to-date version can be found on this website. In case there is an important change that we want to highlight to you, we will also inform you in another appropriate way (for example, via a pop-up notice or statement of changes on our website). See the previous version of this Privacy Policy.
As used in this Privacy Policy, “personal information” or “personal data” means information that relates to an identified individual or to an identifiable individual. For example, this could include among other things your name, address, email address, business contact details, information gathered through your interactions with us via our websites, data concerning your health, or your personal opinions, perceptions, behaviors. Personal information is also referred to as “information about you.” For more detail about the types of information about you that we may process, please refer to Section 4 below.
Find out what categories of personal information Oracle processes.
Find out how Oracle obtains your personal information.
Find out how Oracle uses personal information.
Find out how Oracle discloses personal information within Oracle and with third parties.
Exercise your privacy rights (opt-out, deletion, correction, or access) by filling out our inquiry form.
Contact the Global Data Protection Officer with any questions or concerns.
This Privacy Policy applies to the processing of personal information by Oracle when you have provided your personal information for a research study conducted by Oracle or by a third party acting on behalf of Oracle. We will process the personal information provided by you voluntarily in the context of such study and only for the study purpose disclosed at the point of collection.
The Privacy Policy does not apply to the following activities:
Oracle Corporation and Oracle America, Inc., having their registered address at 2300 Oracle Way, Austin, TX, 78741, USA, are responsible for processing your personal information in scope of this Privacy Policy, except as noted below for Cerner Enviza.
Cerner Enviza has been acquired by Oracle and the below affiliates are in varying stages of transition to the Oracle Life Sciences Healthcare Research Privacy Policy. The provisions of the Cerner Enviza Privacy Policy will remain active until the integration is complete. Please see the Cerner Enviza Privacy Policy for information on these entities’ processing activities.
Cerner Enviza and its affiliated entities are responsible for processing your personal information described in the Cerner Enviza Privacy Policy: Diamond (KH) China AssetCo, Diamond Korea AssetCo Ltd, and ZEG-Zentrum für Epidemiologie und Gesundheitsforschung Berlin GmbH.
Oracle can process information about you collected directly from you when you sign up to participate in an Oracle commissioned research study. Information about you may also be provided to Oracle by third parties who collect information about you on behalf of Oracle. Oracle may also process publicly available data (e.g., social media or publications) for validation purposes.
Specific pieces of information about you that Oracle may collect and process depending on your interaction with Oracle, which may include data from research surveys conducted by Oracle or by third parties on behalf of Oracle:
Oracle may collect personal information that is classified as special categories of personal data or sensitive data personal information. This includes racial or ethnic origin, political opinions, religious or philosophical beliefs, or trade union membership, genetic data, biometric data for the purpose of uniquely identifying a natural person, data concerning health or data concerning a natural person’s sex life or sexual orientation. Such data may include your health status, such as conditions you may suffer from or diagnoses and treatments. You can choose whether to provide this data to us.
In order to prevent multiple entries in studies by the same individuals, or to assign the correct study to you (e.g., we may have a longitudinal study requiring regular participation over a period of time), we will assign you a unique ID or use your IP address, browser specification or unique identifiers such as Medical Education (ME) number or National Provider Identifier (NPI). If so, we will disclose this activity at the beginning of each of these studies.
We may use personal information for the following commercial purposes:
We may use personal information for the following business purposes:
These purposes are described below in further detail.
To conduct observational longitudinal studies that monitor and analyze your habits, health, treatment patterns over a period of time.
As an example, observational studies may be conducted over a period of years to better understand health conditions that researchers are interested in further understanding.
To conduct clinical trials to analyze treatment plans (including medical, surgical, or behavioral intervention or the use of a drug or medical device) to understand the impact of such treatment on data subjects and to better inform effective treatments
If you choose to participate in a research study conducted by Oracle or by a third party acting in cooperation with Oracle, we process personal information provided by you voluntarily in the context of the study and for the study purpose. The scope of our studies could be e.g., to understand your views about certain products and services or to understand your behavior in different situations.
To analyze, study, participate and generate reports in an Oracle research study
Oracle processes personal information contained in research study results and findings.
To better understand prescribing and treatment patterns using publicly available information which may include personal information on Influencers/Key Opinion Leaders (KOLs)
We may collect the publicly available on Influencers/Key Opinion Leaders (KOLs) in a given disease, therapeutic or expertise area. We will then use publicly available resources (e.g., social media or publications) to validate the Influencers/KOLs’ personal details to build a database to better understand prescribing and treatment patterns and influence in given disease, therapeutic or expertise areas, and share with industry sponsors who may use it to understand the sharing of knowledge between healthcare system and possible purposes of participation in educational programs, speaker opportunities, or clinical trials, etc.
To communicate and respond to your requests and inquiries to Oracle
If you get in touch with us, we process information about you to communicate with you and to respond to your requests or other inquiries.
To provide payment via bank or gift cards to study participants
In limited circumstances, we may collect bank or payment details (as well as any required government identifiers) to reimburse a study participant for any costs associated with the study or for the participant’s time, inconvenience or other consideration. Such circumstances would be voluntary for participants and further information would be provided to you at the onset of the study.
To analyze, develop, improve and optimize the use, function and performance of our sites and products and services
We may process personal information in order to analyze, develop, improve and optimize the use, function and performance of our sites and products and services, including for quality assurance and training purposes.
To manage the security of our sites, facilities, networks and systems
We may collect site use data to validate your identity, for security and operations management to help keep our sites, facilities, networks and systems secure, or to investigate and prevent potential fraud, including ad fraud and cyber-attacks and to detect bots.
To comply with applicable laws and regulations and to operate our business
In some cases, we have to process personal information to comply with applicable laws and regulations. For example, to respond to a request from a regulator or to defend a legal claim. We may also process personal information in the performance and operation of our business, such as to conduct internal audits and investigations or for finance and accounting and archiving and insurance purposes.
For personal information collected about you in the EU/EEA, the UK and other relevant jurisdictions, our basis for processing is the following:
Personal information will be retained only for such period as disclosed at the time of collection or as appropriate for its intended and lawful use, unless otherwise required by law. Personal information that is no longer required will be disposed of in ways that ensure their confidential nature is not compromised.
Sharing within Oracle
As a global organization, information about you may be shared globally throughout Oracle’s worldwide organization. See the list of Oracle entities. Please select a region and country to view the registered address and contact details of the Oracle entity or entities located in each country.
Oracle employees are authorized to access personal information only to the extent necessary to serve the applicable purpose(s) and to perform their job functions.
Disclosing personal information to third parties
We may disclose personal information with the following third parties for a business purpose:
When third parties are given access to personal information, we will take appropriate contractual, technical and organizational measures designed to ensure that personal information is processed only to the extent that such processing is necessary, consistent with this Privacy Policy, and in accordance with applicable law.
As a global organization, information about you may be shared globally throughout Oracle’s worldwide organization. See the list of Oracle entities. Please select a region and country to view the registered address and contact details of the Oracle entity or entities located in each country.
Oracle is a global corporation with operations in over 80 countries and personal information is processed globally as necessary in accordance with this policy. If personal information is transferred to an Oracle recipient in a country that does not provide an adequate level of protection for personal information, Oracle will take adequate measures designed to protect the personal information, such as ensuring that such transfers are subject to the terms of the EU Model Clauses or other adequate transfer mechanism as required under relevant data protection laws.
Oracle has implemented appropriate technical, physical and organizational measures designed to protect personal information against accidental or unlawful destruction or accidental loss, damage, alteration, unauthorized disclosure or access, as well as all other forms of unlawful processing.
You can exercise your privacy rights in accordance with applicable laws as specified on our Privacy Choices page, or by filling out our inquiry form. You have multiple privacy rights, subject to applicable law, in respect of the information we process about you:
If you are authorized to make an access or deletion request on behalf of a data subject, please reach out to us via the inquiry form and indicate that you are an authorized agent. We will provide you with instructions on how to submit a request as an authorized agent on behalf of a data subject.
If your inquiry relates to your company’s service account or support of Oracle products or services, please note the Oracle Privacy team cannot delete, correct, or access service account data or terminate your contracted Oracle product or service account. Please go to the Contact Oracle page for resources and contact information to administer service account data.
Sensitive personal information
Oracle may collect personal information that is classified as “special categories” of personal information. This includes racial or ethnic origin, political opinions, religious or philosophical beliefs, or trade union membership, genetic data, biometric data for the purpose of uniquely identifying a natural person, data concerning health or data concerning a natural person's sex life or sexual orientation. You can choose whether to provide this data to us.
Children’s privacy
In limited circumstances, as part of specific clinical trials, personal data about a child may be processed with parental consent per the disclosure and consent collected at the time of collection. Please follow the procedures in Section 12 to exercise privacy rights on behalf of your child.
Under the California Consumer Privacy Act (CCPA), as amended, California residents may request that we:
1. Disclose to you the following information:
2. Delete personal information we collected from you or correct inaccurate personal information about you (see Section 12); or
3. Opt-out of any future sale of personal information about you (see Section 12).
We will respond to your request consistent with applicable law. If you are an authorized agent making an access or deletion request on behalf of a Californian resident, please reach out to us via the inquiry form and indicate that you are an authorized agent. We will provide you with instructions on how to submit a request as an authorized agent on behalf of a Californian resident.
If you are a California resident, you may obtain information about exercising your rights, as described above, by contacting us at 1-800-633-0748. For information on the CCPA requests Oracle received, complied with, or denied for the previous calendar year, please visit Oracle’s Annual Consumer Privacy Reporting page, available here.
Oracle has appointed a Global Data Protection Officer. If you believe your personal information has been used in a way that is not consistent with the Privacy Policy or your choices, or if you have further questions, comments or suggestions related to this Privacy Policy, please contact the Global Data Protection Officer by filling out an inquiry form. Alternatively, you may reach out to the research investigator, who is in charge of the study in which you are participating in, for information on your rights.
Written inquiries to the Global Data Protection Officer may be addressed to:
Oracle Corporation
Global Data Protection Officer
Willis Tower
233 South Wacker Drive
45th Floor
Chicago, IL 60606
U.S.A.
For personal information collected about you in the EU/EEA or other relevant regions, the EU Data Protection Officer can be contacted by filling out an inquiry form and selecting “Contact Oracle’s external EU DPO” in the dropdown menu. Written inquiries may be addressed to:
Robert Niedermeier
Hauptstraße 4
D-85579 Neubiberg / München
Germany
For personal information collected from individuals INSIDE Brazil, written inquiries to the Brazilian Data Protection Officer may be addressed to:
Alexandre Sarte
Rua Dr. Jose Aureo Bustamante, 455
Vila São Francisco
São Paulo, BR
If you have any complaints regarding our compliance with this Privacy Policy, please contact us. We will investigate and attempt to resolve complaints and disputes regarding use and disclosure of personal information in accordance with this Privacy Policy and in accordance with applicable law. You also have the right to file a complaint with a competent data protection authority.
Oracle’s corporate headquarters are located at:
2300 Oracle Way
Austin, TX 78741
USA
Tel: +1.737.867.1000
Information notice on personal data protection in the context of studies requiring access to data from the National Health Data System (SNDS).
The context
The National Health Data System (SNDS) was created by the law on the modernization of the health system (Law No. 2016-41 of January 26, 2016, available on the Legifrance website) and it was established by the National Health Insurance Fund (Cnam).
The SNDS collects a set of medico-administrative data fed by different databases and covering almost the entire French population under the responsibility of the Health Insurance. The Law on the organization and transformation of the healthcare system of 2019 (Law No. 2019-774 of 24 July 2019, available on the Legifrance website) has further extended its scope to include categories of complementary data.
The main components of the SNDS can be requested to the Cnam on its portal to carry out health research studies under certain conditions.
Access to data from the National Health Data System (SNDS) may be granted if a collective information note is posted on both of the websites of the entities representing and in charge of the research: the health institution (sponsor of the study) identified as the controller, and Oracle identified as the responsible for the implementation of the data processing of the SNDS.
In accordance with the provisions of Article 14.5(b) of the General Data Protection Regulation (GDPR), this collective information note describes the measures implemented in the context of health research, studies and evaluations requiring access to data from the National Health Data System (SNDS) that does not allow or require individual information.
This notice informs you about how we collect, use, disclose and store information about SNDS data.
As the implementation manager, we process the data on behalf of our clients, Sponsors of the studies. The processing is based on the legitimate interest of our clients, in order to progress scientific research for the development and evaluation of health care.
In addition to this collective information note and to meet the legal obligations of information and transparency on the use of data of the SNDS, the various studies are also referenced in a public directory maintained by the Health Data Hub (HDH) publicly available on its website.
Data sources
This note applies to all health research, studies and assessments using data from the SNDS, including:
The data processed in the SDNS are data relating to hospitalizations (disease responsible for hospitalization and associated comorbidities) and/or data relating to reimbursed care provided outside of hospital settings (medical consultation, delivery of treatments, medical acts, ...)
How and why SNDS data is used
We use and analyze the data of the SNDS according to a protocol specific to each study that has been approved by CESREES (Ethical and Scientific Committee for Health Research, Studies and Assessments). CESREES is responsible for the approval of studies requiring the use of personal health data, before getting the authorization of the CNIL.
The objectives of scientific research include epidemiological, pharmaco-epidemiological and health economics studies. No analysis shall be performed with the purpose of promoting products to health professionals or institutions or for insurance purposes. The processing of the data concerned is in the public interest and is the subject of scientific communications such as conferences and peer-reviewed journals.
We are committed to implementing appropriate technical and organisational measures to ensure that only unidentified data is used, data minimisation practices are followed and ethical standards are maintained.
Data Privacy
In accordance with the requirements of the Public Health Code, the personal data contained in these databases do not allow the identification of the individuals to which they relate. These data are called "pseudonymised" to preserve the privacy of persons: no surname, first name, address or social security number appears.
The presentation of the results of these studies may in no way permit the direct or indirect identification of the persons concerned. And no reconciliation (data intersection) of the results is possible with other personal data.
People with access to data
The conditions for making the SNDS available are strictly regulated by law. The studies are carried out only through design offices, such as Oracle, which has made a compliance commitment to the Commission Nationale de l'Informatique et des Libertés (CNIL).
For example, only authorized Oracle personnel can access SNDS data for scientific research purposes, subject to professional secrecy in accordance with Articles 226-13 and 223-14 of the Criminal Code. Data is made available through a secure platform from Cnam, without exporting any personal data. No third party, including our clients, has access, directly or indirectly, to the data of the SNDS. Only aggregated and anonymous results may be communicated and in no case allow the direct or indirect identification of the persons concerned.
Data retention
The retention period of the data processed in the context of these studies shall be the period necessary for carrying out the study and is justified by the controller. Data may be retained at the end of the study for a maximum period of two years from the last publication on the results.
Exercising your rights
In accordance with the provisions of Article R. 1461-9 of the Public Health Code, you have several rights in relation to your personal data. You can access and request rectification of your data, as well as object to their processing for research, study or evaluation purposes. You can exercise your rights by contacting the director of the managing body of the compulsory health insurance plan to which you belong. Oracle does not have your identity as part of this research and will not be able to identify you to enable you to exercise your rights.
You also have the right to file a claim with the Commission Nationale de l'Informatique et des Libertés (CNIL), online or by mail at 3 Place de Fontenoy - TSA 80715 - 75334 PARIS CEDEX 07.Oracle has also designated a Data Protection Officer who you may contact at: privacy-oraclelifesciences_ww@oracle.com.
SNDS Documents
Contact Oracle's Privacy Team regarding a marketing privacy-related question, comment, or issue.